General Information of the Compound
| Compound ID |
CP0396229
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-(1-cyclooctylpiperidin-4-yl)-3,4-dihydroquinolin-2-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C22H32N2O
|
||||||||||||||||||
| Molecular Weight |
340.511
|
||||||||||||||||||
| Canonical SMILES |
O=C1CCc2ccccc2N1C1CCN(CC1)C1CCCCCCC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C22H32N2O/c25-22-13-12-18-8-6-7-11-21(18)24(22)20-14-16-23(17-15-20)19-9-4-2-1-3-5-10-19/h6-8,11,19-20H,1-5,9-10,12-17H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
UWHCRJORVQCFBL-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00983, Kappa-type opioid receptor
Protein ID: PT01515, Mu-type opioid receptor
Protein ID: PT01360, Nociceptin receptor